Obesity, Metabolism and Breast Cancer Metastasis
Obesity, Metabolism and Breast Cancer Metastasis
批准号:
9759569
负责人:
Stephen D Hursting
金额:
$47.25万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2019
资助国家:
美国
项目状态:
已结题
起止时间:
2019-02-01 至 2024-01-31
关键词:
AddressAdoptionAnimal ModelBreast Cancer CellBreast Cancer Risk FactorBreast Epithelial CellsBreast cancer metastasisCell Culture TechniquesCell ProliferationCell SurvivalCellsCessation of lifeChemicalsCitric Acid CycleDevelopmentDiseaseDistalEnergy MetabolismEnvironmentEnzymesExtracellular MatrixFatty AcidsFutureGeneticGlucoseInterventionLeptinLife ExpectancyLife StyleLightLinkLungMalignant NeoplasmsMammary glandMetabolicMetabolismMetastatic Neoplasm to the LungMetastatic toModelingMolecularNeoplasm MetastasisNutrientObesityObesity EpidemicOrganOverweightOxaloacetatesOxygenPatientsPositioning AttributePrimary NeoplasmProcessPyruvatePyruvate CarboxylaseQuality of lifeRecommendationRecurrenceRegulationReporterResearchRiskRoleSiteStable Isotope LabelingStressSystemTestingTissuesUp-RegulationWomanWorkadipokinesbasebreast cancer progressionbreast tumorigenesiscell typeevidence based guidelinesfatty acid metabolismflexibilitygenetic manipulationin vivo Modelinhibitor/antagonistleptin receptormalignant breast neoplasmmetabolomicsmigrationmortality riskmouse modelneoplastic celloverexpressionpreventreceptor expressiontargeted treatmenttumortumor metabolism
中文摘要
项目摘要
虽然有大量证据表明肥胖会增加转移的风险,但分子水平
肥胖导致乳腺癌转移进展的机制尚不清楚。此外,本发明还
最近对癌症发展和进展的研究强调了代谢重编程的作用,
这导致增加的细胞增殖所必需的细胞构件的供应增加
以及在不断变化的营养和含氧环境中细胞生存所需的适应性。
我们团队和其他人的研究表明,代谢酶丙酮酸羧化酶是
在肥胖期间上调,并且这种上调与乳腺癌进展密切相关。
另外的研究表明,瘦素是一种脂肪因子,在肥胖时表达增加,
受体的表达在转移细胞中增强,驱动乳腺癌中丙酮酸羧化酶的表达
细胞重要的是,最近的研究表明,丙酮酸羧化酶的遗传缺失大大抑制了
乳腺癌转移在几个同基因小鼠模型。尽管有证据表明丙酮酸
羧化酶在肥胖条件下有助于乳腺癌转移,这一机制
酶发挥这种作用仍然知之甚少。在拟议的研究中,研究小组将评估
丙酮酸羧化酶调节肥胖驱动的乳腺癌转移的机制基础。他们
将测试瘦素增加乳腺组织中丙酮酸羧化酶表达的假设,
丙酮酸羧化酶对于细胞外基质的迁移和存活都是至关重要的
分离,提供代谢灵活性(例如,葡萄糖利用和脂肪酸代谢)
转移这些假设将通过完成以下目标进行测试:1)定义
转移过程中PC表达的机制; 2)阐明PC表达的代谢机制,
促进转移; 3)建立瘦素调节PC表达有助于转移的机制。
肥胖导致的转移完成这些研究将产生有价值的机械信息,
指导今后为超重和肥胖者制定循证建议,
这将有助于减少乳腺癌转移。
英文摘要
PROJECT SUMMARY
While significant evidence has demonstrated that obesity increases the risk of metastasis, the molecular
mechanisms by which obesity contributes to the metastatic progression of breast cancer are unclear. Further,
recent research in cancer development and progression has highlighted the role of metabolic reprogramming,
which results in an increased supply of the cellular building blocks necessary for the increased cell proliferation
and in adaptations required for cell survival in changing nutrient- and oxygen-containing environments.
Research from our team and others demonstrates that the metabolic enzyme, pyruvate carboxylase, is
upregulated during obesity and that this upregulation correlates strongly with breast cancer progression.
Additional studies suggest that leptin, an adipokine whose expression is increased during obesity and whose
receptor's expression is enhanced in metastatic cells, drives pyruvate carboxylase expression in breast cancer
cells. Importantly, recent studies demonstrate that genetic depletion of pyruvate carboxylase drastically inhibits
breast cancer metastasis in several syngeneic mouse models. Despite the supporting evidence that pyruvate
carboxylase contributes to breast cancer metastasis under obese conditions, the mechanisms by which this
enzyme exerts this effect remain poorly understood. In the proposed studies, the research team will evaluate
the mechanistic basis by which pyruvate carboxylase regulates obesity-driven breast cancer metastasis. They
will test the hypotheses that leptin increases pyruvate carboxylase expression in mammary tissue during
obese states, and that pyruvate carboxylase is critical for both migration and survival of extracellular matrix
detachment, providing metabolic flexibility (e.g., glucose utilization and fatty acid metabolism) during
metastasis. These hypotheses will be tested through completion of the following aims: 1) define the
mechanisms of PC expression during metastasis; 2) elucidate the metabolic mechanisms by which PC
promotes metastasis; and 3) establish the mechanisms by which leptin-regulated PC expression contributes to
obesity-driven metastasis. Completion of these studies will result in valuable mechanistic information that could
guide future development of evidence-based recommendations for those who are overweight and obese and
that will help reduce breast cancer metastasis.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Impact of hypoxia on lipid metabolism in obesity-driven breast cancer progression
-
批准号:10604919
-
项目类别:
-
资助金额:$65.54万
-
财政年份:2022
-
负责人:Stephen D Hursting
-
依托单位:
Adipose tissue-colorectal tumor cross-talk: new targets for breaking the obesity-cancer link
-
批准号:10229282
-
项目类别:
-
资助金额:$67.71万
-
财政年份:2021
-
负责人:Stephen D Hursting
-
依托单位:
Adipose tissue-colorectal tumor cross-talk: new targets for breaking the obesity-cancer link
-
批准号:10683262
-
项目类别:
-
资助金额:$62.75万
-
财政年份:2021
-
负责人:Stephen D Hursting
-
依托单位:
Adipose tissue-colorectal tumor cross-talk: new targets for breaking the obesity-cancer link
-
批准号:10493126
-
项目类别:
-
资助金额:$62.14万
-
财政年份:2021
-
负责人:Stephen D Hursting
-
依托单位:
Obesity, Metabolism and Breast Cancer Metastasis
-
批准号:10381300
-
项目类别:
-
资助金额:$11.66万
-
财政年份:2021
-
负责人:Stephen D Hursting
-
依托单位:
Obesity, Metabolism and Breast Cancer Metastasis
-
批准号:10548139
-
项目类别:
-
资助金额:$44.96万
-
财政年份:2019
-
负责人:Stephen D Hursting
-
依托单位:
Obesity, Metabolism and Breast Cancer Metastasis
-
批准号:10524122
-
项目类别:
-
资助金额:$18.63万
-
财政年份:2019
-
负责人:Stephen D Hursting
-
依托单位:
Obesity, Metabolism and Breast Cancer Metastasis
-
批准号:10319580
-
项目类别:
-
资助金额:$44.96万
-
财政年份:2019
-
负责人:Stephen D Hursting
-
依托单位:
Obesity, Metabolism and Breast Cancer Metastasis
-
批准号:10079476
-
项目类别:
-
资助金额:$45.88万
-
财政年份:2019
-
负责人:Stephen D Hursting
-
依托单位:
Breaking the Obesity-Cancer Link: New Targets and Strategies
-
批准号:8956135
-
项目类别:
-
资助金额:$76.26万
-
财政年份:2015
-
负责人:Stephen D Hursting
-
依托单位:
Breaking the Obesity-Cancer Link: New Targets and Strategies
-
批准号:9117547
-
项目类别:
-
资助金额:$76.26万
-
财政年份:2015
-
负责人:Stephen D Hursting
-
依托单位:
Breaking the Obesity-Cancer Link: New Targets and Strategies
-
批准号:9764294
-
项目类别:
-
资助金额:$72.69万
-
财政年份:2015
-
负责人:Stephen D Hursting
-
依托单位:
Akt/mTOR Signaling in Energy Balance Modulation of Epithelial Carcinogenesis
-
批准号:8223255
-
项目类别:
-
资助金额:$30.8万
-
财政年份:2009
-
负责人:Stephen D Hursting
-
依托单位:
Akt/mTOR Signaling in Energy Balance Modulation of Epithelial Carcinogenesis
-
批准号:7655953
-
项目类别:
-
资助金额:$33.05万
-
财政年份:2009
-
负责人:Stephen D Hursting
-
依托单位:
Akt/mTOR Signaling in Energy Balance Modulation of Epithelial Carcinogenesis
-
批准号:8027757
-
项目类别:
-
资助金额:$30.8万
-
财政年份:2009
-
负责人:Stephen D Hursting
-
依托单位:
Akt/mTOR Signaling in Energy Balance Modulation of Epithelial Carcinogenesis
-
批准号:7821406
-
项目类别:
-
资助金额:$31.75万
-
财政年份:2009
-
负责人:Stephen D Hursting
-
依托单位:
Akt/mTOR Signaling in Energy Balance Modulation of Epithelial Carcinogenesis
-
批准号:8444652
-
项目类别:
-
资助金额:$28.95万
-
财政年份:2009
-
负责人:Stephen D Hursting
-
依托单位:
Animal Metabolism Phenotyping Core
-
批准号:10170771
-
项目类别:
-
资助金额:$15.55万
-
财政年份:1999
-
负责人:Stephen D Hursting
-
依托单位:
Animal Metabolism Phenotyping Core
-
批准号:10601026
-
项目类别:
-
资助金额:$14.71万
-
财政年份:1999
-
负责人:Stephen D Hursting
-
依托单位:
Animal Metabolism Phenotyping Core
-
批准号:10373074
-
项目类别:
-
资助金额:$14.95万
-
财政年份:1999
-
负责人:Stephen D Hursting
-
依托单位:
海外基金